PIM
ANAC

Provident Investment Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Provident Investment Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,500
Closed -$348K – 56
2015
Q2 		$348K Sell
4,500
-1,200
-21% -$78.7K 0.07% 44
2015
Q1 		$330K Sell
5,700
-1,800
-24% -$76.4K 0.07% 46
2014
Q4 		$242K Buy
+7,500
New +$225K 0.05% 52

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Provident Investment Management's ANAC Position: Q3 2015 in Review

Provident Investment Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2015, closing a stake of 4,500 shares — an estimated $348K sold.

Provident Investment Management first reported a position in ANAC in Q4 2014 and held it in 3 quarters. The position peaked at $348K in Q2 2015. 213 funds tracked by Wall St. Rank hold ANAC as of Q3 2015.

  • Provident Investment Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2015 after selling out during the quarter.
  • Provident Investment Management sold 4,500 ANACOR PHARMACEUTICALS INC COM shares in Q3 2015, an estimated $348K.
  • Provident Investment Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 3 quarters.
  • Provident Investment Management's ANACOR PHARMACEUTICALS INC COM position peaked at $348K in Q2 2015.
  • 213 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2015.

Based on Provident Investment Management's 13F filing for Q3 2015, filed 9 Nov 2015.